Chinese biopharma firm CStone gets $150m Series A from Oriza, Boyu, WuXi

Chinese biopharma firm CStone gets $150m Series A from Oriza, Boyu, WuXi

Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures have jointly invested in a bio-pharmaceutical firm CStone Pharmaceuticals’ series A financing round of $150 million, the companies said in a statement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter